COINSHARES I. LS-000247 Net Assets
COINSHARES I. LS-000247 net assets. Based on the latest financial reports, COINSHARES I. LS-000247 (3TW) has net assets worth €410.09 Million EUR (≈ $479.44 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€6.18 Billion ≈ $7.23 Billion USD) and total liabilities (€5.77 Billion ≈ $6.75 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore COINSHARES I. LS-000247 (3TW) net asset momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €410.09 Million |
| % of Total Assets | 6.63% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 51.74 |
Net Assets of COINSHARES I. LS-000247 (2021–2025)
Net assets of COINSHARES I. LS-000247 from 2021 to 2025. This chart illustrates how COINSHARES I. LS-000247's net assets have evolved over time, based on quarterly financial data. See 3TW equity financing ratio to measure how much of total assets are equity-financed.
Annual Net Assets for COINSHARES I. LS-000247 (2021–2025)
The table below shows the annual net assets of COINSHARES I. LS-000247 from 2021 to 2025. For live market cap and overall valuation, see 3TW market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €-1.41K ≈ $-1.65K |
-100.00% |
| 2024-12-31 | €393.95 Million ≈ $460.56 Million |
+29.26% |
| 2023-12-31 | €304.77 Million ≈ $356.31 Million |
+23.61% |
| 2022-12-31 | €246.57 Million ≈ $288.26 Million |
-8.66% |
| 2021-12-31 | €269.95 Million ≈ $315.59 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to COINSHARES I. LS-000247's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
COINSHARES I. LS-000247 Net Assets Breakdown (December 2025)
COINSHARES I. LS-000247 net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €150.00K | % |
| Total Equity | €-1.41K | 100.00% |
COINSHARES I. LS-000247 Competitors by Market Cap
The table below lists competitors of COINSHARES I. LS-000247 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Aberdeen Standard Global Infrastructure Income Fund
NYSE:ASGI
|
$472.62 Million |
|
Regenxbio Inc
NASDAQ:RGNX
|
$472.65 Million |
|
Cerus Corporation
NASDAQ:CERS
|
$472.87 Million |
|
Semco Technologies Sas
PA:ALSEM
|
$472.91 Million |
|
Jee Technology Co. Ltd. A
SHG:688162
|
$472.46 Million |
|
Eastern & Oriental Bhd
KLSE:3417
|
$472.43 Million |
|
KraussMaffei Co Ltd
SHG:600579
|
$472.38 Million |
|
Zhejiang Tengen Electrics Co Ltd
SHG:605066
|
$471.97 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in COINSHARES I. LS-000247's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 393,946,043 to -1,410, a change of -393,947,453 (-100.0%).
- Other factors decreased equity by 393,947,453.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €0.00 | -0.0% |
| Other Changes | €-393.95 Million | -27939535.68% |
| Total Change | €- | -100.00% |
Book Value vs Market Value Analysis
This analysis compares COINSHARES I. LS-000247's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | €3.96 | €7.21 | x |
| 2022-12-31 | €3.62 | €7.21 | x |
| 2023-12-31 | €4.58 | €7.21 | x |
| 2024-12-31 | €5.91 | €7.21 | x |
| 2025-12-31 | €0.00 | €7.21 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently COINSHARES I. LS-000247 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 33.24%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 119.50%
- • Asset Turnover: 0.02x
- • Equity Multiplier: 15.29x
- Recent ROE (33.24%) is above the historical average (-224.52%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -1206.08% | -2987.22% | 0.02x | 20.01x | €-3.28 Billion |
| 2022 | 255.33% | 1013.34% | 0.04x | 6.11x | €604.91 Million |
| 2023 | 19.41% | 107.79% | 0.02x | 11.42x | €28.68 Million |
| 2024 | 33.24% | 119.50% | 0.02x | 15.29x | €91.55 Million |
Industry Comparison
This section compares COINSHARES I. LS-000247's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| COINSHARES I. LS-000247 (3TW) | €410.09 Million | -1206.08% | 14.07x | $472.53 Million |
| Covestro AG (1COV) | $6.68 Billion | -3.98% | 1.04x | $11.10 Billion |
| CENTESSA PHARMACEUTICALS (260) | $401.55 Million | -58.71% | 0.44x | $5.35 Billion |
| 2invest AG (2INV) | $61.58 Million | -34.16% | 0.01x | $70.69 Million |
| Adaptimmune Therapeutics plc (473A) | $123.64 Million | -110.94% | 0.47x | $42.94 Million |
| KINGMAN MINERALS LTD. (47A) | $1.72 Million | -14.34% | 0.35x | $4.05K |
| GENOR BIOPHARMA DL-00002 (67N0) | $2.49 Billion | -34.70% | 0.15x | $93.97 Million |
| BENO Holding AG (BENH) | $16.45 Million | 13.33% | 2.75x | $72.92K |
| Biotest Aktiengesellschaft (BIO) | $253.37 Million | 11.10% | 1.34x | $976.15 Million |
| Biotest Aktiengesellschaft (BIO3) | $110.79 Million | 17.87% | 2.36x | $656.94 Million |
About COINSHARES I. LS-000247
CoinShares PLC engages in the creating financial products with digital assets and blockchain technology business in Jersey. It operates through three segments: Asset Management, Capital Markets, and Principal Investments. The company offers CoinShares Physical, CoinShares Valkyrie, CoinShares XBT, and The Blockchain Global Equity Index products. It also provides hedge fund solutions, indices, ven… Read more